Skip to main content
PetMed Express, Inc. (PETS)
NASDAQ: PETS · Real-Time Price · USD
1.650
-0.080 (-4.62%)
At close: Dec 5, 2025, 4:00 PM EST
1.737
+0.087 (5.28%)
After-hours: Dec 5, 2025, 6:09 PM EST

PetMed Express Revenue

In the fiscal year ending March 31, 2025, PetMed Express had annual revenue of $226.97M, down -17.19%. PetMed Express had revenue of $46.47M in the quarter ending March 31, 2025, a decrease of -21.95%.

Revenue (ttm)
$226.97M
Revenue Growth
-17.19%
P/S Ratio
0.15
Revenue / Employee
$1,311,977
Employees
173
Market Cap
34.65M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Mar 31, 2025226.97M-47.12M-17.19%
Mar 31, 2024274.10M26.53M10.71%
Mar 31, 2023247.57M-24.71M-9.08%
Mar 31, 2022272.28M-31.30M-10.31%
Mar 31, 2021303.58M19.46M6.85%
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro
Mar 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 435.16B
Johnson & Johnson 92.15B
Merck & Co. 64.24B
AbbVie 59.64B
Eli Lilly and Company 59.42B
AstraZeneca 58.13B
Novartis AG 56.37B
Novo Nordisk 49.58B
Revenue Rankings

PETS News

More News